Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Johnson & Johnson (JNJ) Wins Label Expansion Approval For Antipsychotic Drug
Johnson & Johnson (JNJ) Wins Label Expansion Approval For Antipsychotic Drug
Johnson & Johnson (JNJ) Wins Label Expansion Approval For Antipsychotic Drug
Submitted by
admin
on November 14, 2014 - 11:01am
Source:
Bidness Etc.
News Tags:
JNJ
Janssen
antipsychotics
Invega Sustenna
schizophrenia
Headline:
Johnson & Johnson (JNJ) Wins Label Expansion Approval For Antipsychotic Drug
Do Not Allow Advertisers to Use My Personal information
